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Ten ways to improve information technology in the NHS
Users, not geeks, should design interface
Editor—With reference to the article by
Majeed et al,1 the consultation is central to
medicine, and information technology must
facilitate it. With the constant changes in
information technology it remains nascent,
disjointed, and user hostile. It is no surprise
that implementation remains problematic.
Paper records will be superseded, but
successors must emulate their familiarity
and simplicity.
The authors do not mention the main
weakness—what users see and what they can
do with it. Background issues (coding,
networks, intranets, security, maintenance,
data transfer, etc) are the province of geeks.
Even the brand leader (EMIS) is difficult to
operate in consultation, and its presentation
of data, especially lab results, is dire.
Interfaces operated by hand via large
colour liquid crystal display touch screens
are the technologies that can transform
health computing by rendering the con-
sultation process “natural.” Healthcare
computing will be wonderful when the user
can use it easily. Get users, not geeks, to
design the interface, and the project will
take wing.
Steven Ford general practitioner
Health Centre, Haydon Bridge NE47 6HG
sford-hb@dircon.co.uk
Competing interests: None declared.
1 Majeed A, de Lusignan S. Ten ways to improve
information technology in the NHS [with commentary by
S Teasdale]. BMJ 2003;326:202-6. (25 January.)
Any change in information technology in
general practice requires extensive
piloting
Editor—I disagree with Majeed et al’s con-
tention that better information technology
support for practices requires locating
patients’ records on central servers.1 Good
support for practice based servers may be a
better choice.
Running a primary care trust’s records
on a single server is a high risk strategy that
makes the entire functioning of primary
care in a locality vulnerable to any problem
with the central server and makes a
practice’s access to its records vulnerable to
problems with its telecommunications links.
Access to information on patients’
records must be instantaneous. With very
short consultation times we cannot afford
even brief delays, which would result in
practitioners not bothering to access as
much information from records as they
otherwise might. Any proposed system
based on a central server should be piloted
for at least a year before committing to a
wider rollout.
Patients’ records are currently deterio-
rating with manual re-entry (usually by staff
who are not medically qualified) of impor-
tant details from the vast printouts handed
on by paperless practices. We urgently need
not only a transferable structure for elec-
tronic records made by general practitioners
but also a mandated standard filing struc-
ture for scanned correspondence. Every
paperless practice is currently inventing its
own, which will have dire consequences for
the future functionality of electronically
transferred correspondence files.
Duncan Keeley general practitioner
Thame OX9 3JZ
yc23@dial.pipex.com
Competing interests: None declared.
1 Majeed A, de Lusignan S. Ten ways to improve
information technology in the NHS [with commentary by
S Teasdale]. BMJ 2003;326:202-6. (25 January.)
Article states the obvious
Editor—The interest in Majeed et al’s
article on ten ways to improve NHS
information technology highlights the fun-
damental mismatch of perspectives between
management and doctors.1
An effective solution can work only if the
approach is patient centred. This conceptual
naivety is striking when doctors try to tell the
government how to do its job. Of course the
government can’t do much better. It has
pumped hundreds of millions of pounds
into the NHS information technology
system over the past 10 years, and what has
it to show for it?
Every point in the article was thought of
15 years ago. The problem is not a shortage
of needs but one of delivery. It is not about
need but implementation. The government
has a slightly different agenda from primary
care doctors, and secondary care needs
differ once again.
The government has three bottom lines:
trolley times in accident and emergency
wards, waiting times, and balancing its
books. Any information technology system
must focus on these remits. Hopefully, these
bottom lines are patient focused. However,
whether your aged mother is lying on a trol-
ley or a trolley without wheels (a bed) in an
accident and emergency department is
hardly going to change when the NHS net
becomes efficient.
Murray Flett retired civil servant
Department of Health
MurrayFlett2@hotmail.com
Competing interests: None declared.
1 Majeed A, de Lusignan S. Ten ways to improve
information technology in the NHS [with commentary by
S Teasdale]. BMJ 2003;326:202-6. (25 January.)
Current situation in the United Kingdom
need not be so
Editor—Majeed et al detailed a wish list for
information technology in the NHS.1 For the
past 10 years I have worked in a district gen-
eral hospital in New Zealand. Like that in
Britain the country’s public health system is
under constant pressure from inadequate
funding, chronic understaffing, and escalat-
ing demands from patients, politicians, and
others. Unlike Britain, New Zealand has a
very small population that generates minus-
cule revenues in global terms. Most indices of
health and wealth have declined relentlessly,
in absolute and relative terms, for decades,
Despite this my hospital, and many
others, invested in a modern information
technology system. For years letters have
been dictated over the telephone on to a dig-
ital system for storage or typing. All
correspondence, laboratory results, clinical
photographs, patients’ details, and adminis-
trative records are accessible in seconds from
any terminal. Radiology and histopathology
images are incorporated into the system.
Coming to work in the United Kingdom
was like returning to the technology used in
New Zealand over 10 years ago. Investment
has been little, and staff have received almost
no training in the use of even the most basic
Supporting doctors’ clinical practice comes too low
in the NHS’s IT priorities
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information technology. Facilities that would
not be put up with for one moment at home
are tolerated and endured at work with a
dogged martyrdom.
Paul Heaton consultant paediatrician
Yeovil District Hospital, Yeovil BA21 4AT
heatp@est.nhs.uk
Competing interests: None declared.
1 Majeed A, de Lusignan S. Ten ways to improve
information technology in the NHS [with commentary by
S Teasdale]. BMJ 2003;326:202-6. (25 January.)
Primary care doctors need to become
aware of training opportunities
Editor—Majeed et al call for additional
training to allow all members of the primary
healthcare team to take advantage of
resources such as the National Electronic
Library for Health.1 In our experience, a
wide range of information handling skills
exists among this group, as does a general
lack of awareness of what electronic
information resources are available to them.
We recently appointed a primary care
information skills development officer to
enhance local awareness of electronic and
other information resources and to provide
training to any member of primary care staff
in Oxfordshire in the use of these resources.
The post is funded by Oxfordshire’s local
implementation strategy team.
There have been many similar appoint-
ments in recent years throughout the United
Kingdom. We would urge all primary care
practitioners to contact their nearest health-
care library to find out what local training
opportunities are available.
Donald M Mackay former enquiry services manager
donald.mackay@cairns-library.oxford.ac.uk
Caroline Papi primary care information skills
development officer
Nia Roberts assistant librarian
Cairns Library, University of Oxford Health Care
Libraries, John Radcliffe Hospital, Oxford OX3 9DU
Nicola Bexon information services manager
IHS Library, University of Oxford Health Care
Libraries, Institute of Health Sciences, Oxford
OX3 7LF
Competing interests: None declared.
1 Majeed A, de Lusignan S. Ten ways to improve
information technology in the NHS [with commentary by
S Teasdale]. BMJ 2003;326:202-6. (25 January.)
Computers in the workplace are of great
value
Editor—Melichar and Bland discussed doc-
tors and computers.1 Working at the Mayo
Clinic I have come to appreciate the value of
access to high grade information technol-
ogy. Mayo supports a free internet service
provider to all employees. A 24 hour service
is available to help people at work or at
home. The “microcomputer education serv-
ice” offers classes on how to get the most out
of the software. Every on-call room has
computer access to patients’ electronic
records and all data pertaining to patients’
care. All terminals have access to the
internet and email.
The philosophy of this institution is that
investment in information technology results
in the staff feeling supported and thus more
efficient. The lack of investment in infor-
mation technology in the United Kingdom is
a major hindrance to progress. The “short
termism” in health politics precludes the abil-
ity to improve efficiency in the workplace.
Information technology should be a priority
for spending in the NHS.
Ketan Dhatariya research fellow
Endocrine Research Unit, Joseph 5-194, Mayo
Clinic and Foundation, 200 First Street, Rochester,
MN 55905, USA
dhatariya.ketan@mayo.edu
Competing interests: None declared.
1 Melichar JK, Bland M. Doctors and computers. BMJ
2003;326:220. (25 January.)
Closing the digital divide
Reality may not be so rosy
Editor—Smith applauds the progress made
in providing access to the internet in the
developing world.1 Unfortunately the reality
on the ground may not be as rosy.
I have just completed two years in a
major sub-Saharan African university that
was in the first phase of HINARI access.
Having been initially starved of information
while there I rushed to gain access. Unfortu-
nately I was directed to the websites of two
other international projects that were also
providing free access to research materials
over the internet.
I found poorly presented sites with com-
plex addresses and passwords, and with lim-
ited access to full text journals. I contacted
the projects repeatedly over the following
months from my local internet café, trying
to get better materials, but finally gave up,
frustrated. It was only on my return to the
United Kingdom that I discovered that I had
been directed to the wrong sites. The
HINARI website (www.healthinternetwork.
org/) would have provided all that I needed.
How can we ensure that access to
HINARI is available to those who need it? If
I—as someone who was in the university,
computer literate, and keen to access
journals—failed, then there is little hope for
the rural majority with limited computer
skills.
Communication in countries must be
improved through training programmes
and publicity. But it is also the responsibility
of international projects participating in
information supply to the developing world
to direct casual searchers like myself to good
quality central portals like HINARI rather
than to their own poorer versions. All too
often good resources can be confounded by
interagency competitiveness. To ensure that
the HINARI address is spread as widely as
possible, all need to focus on this major por-
tal so that the users at the sharp end do not
receive confused messages.
Andrew D Weeks lecturer in obstetrics and gynaecology
Liverpool Women’s Hospital, Liverpool L8 7SS
aweeks@Liverpool.ac.uk
Competing interests: None declared.
1 Smith R. Closing the digital divide. BMJ 2003;326:238.
(1 February.)
Financial and technical obstacles must be
eliminated
Editor—Like Smith, I think that HINARI is
an excellent idea and one that has great
potential to improve health care in devel-
oped countries.1 However, I had three
concerns about the current programme.
Firstly, when I looked at the list of
eligible countries, I noted that three south
Asian countries (Pakistan, India, Bangla-
desh) were not included, even though all
three countries would seem ideal candidates
for the HINARI programme (they have a
combined population of over 1000 million
people and a large pool of English speaking
doctors). I wondered therefore why they
were excluded. Of course, their omission
from the list may simply be a clerical error,
but if this is the case, it needs to be corrected.
Secondly, the current uptake of HINARI
seems low given its potential. Smith said that
438 institutions in 68 countries eligible for
free access have signed up thus far. This
gives an average of six or seven institutions
per country, which means that HINARI’s
current penetration is still very low. Hence,
obstacles to the greater uptake of HINARI
need to be identified and overcome.
Thirdly, the $1000 fee payable for access
to journals may be affordable by large insti-
tutions but not by community health centres
or doctors working in singlehanded or small
group practices. We therefore need to
ensure that financial obstacles do not hinder
the uptake of HINARI.
HINARI has great potential to reduce
the digital divide, but we need to ensure that
financial and technical obstacles do not
hinder its uptake.
Malcolm Grant internet consultant
London SW19
mg7765@hotmail.com
Competing interests: None declared.
1 Smith R. Closing the digital divide. BMJ 2003;326:238.
(1 February.)
Folate and risk of
cardiovascular disease
Study results were misinterpreted
Editor—Hung et al conclude that their
cohort study on serum folate and coronary
heart disease provides evidence against the
view that folic acid prevents coronary heart
disease.1 We disagree and believe they have
misinterpreted their results.
A meta-analysis of studies on homo-
cysteine and cardiovascular disease, sup-
ported by others,2–4 together with ran-
domised trial evidence on folic acid dose
and serum homocysteine reduction, shows
that the maximal homocysteine lowering
effect of folic acid occurs at a dose of about
0.8 mg/day (which increases serum folate by
20 g/l).5 This homocysteine reduction low-
ers the risk of coronary heart disease by
about 16%. The difference in average serum
folate between the highest and the lowest
folate group in the cohort study of Hung et
Letters
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al was about 7 g/l, since the median of the
highest folate group was about 8 g/l (the
93rd centile was stated as 9 g/l, so the 85th
centile must have been less than this) and
the median in the lowest folate group was
about 1 g/l (stated as < 3 g/l).
Since a 20 mg/l higher serum folate is
associated with a 16% higher risk of coronary
heart disease the 7 g/l difference will be
associated with a 5% higher risk, a relative risk
of 1.05 (1.167/20) consistent with the 1.10
(men) and 1.14 (women) in their study. These
results weigh in favour, not against, the view
that folic acid reduces the risk of coronary
heart disease. The narrow range of serum
folate values in their cohort study limits its
ability to show a significant effect.
Table 4 in the paper confirms the link
between low serum folate and increased risk
of coronary heart disease. Hung et al present
data from six other cohort studies. Each
shows a higher risk of coronary heart disease
in the lowest folate group compared with the
highest. This observation alone is highly
significant. The probability that all seven
studies have estimates above 1.0 by chance
alone is (Y)7 or 1 in 128, a P value of 0.008.
Their negative conclusion is inappropriate.
David S Wald specialist registrar in cardiology
Southampton General Hospital, Southampton
SO16 6YD
davidwald@hotmail.com
Malcolm Law professor
Joan Morris senior lecturer
Nicholas J Wald professor
Department of Environmental and Preventive
Medicine, London EC1M 6BQ
Competing interests: None declared.
1 Hung J, Beilby JP, Knuiman MW, Divitini M. Folate and
vitamin B-12 and risk of fatal cardiovascular disease:
cohort study from Busselton, Western Australia. BMJ
2003;326:131-6. (18 January.)
2 Wald DS, Law M, Morris JK. Homocysteine and cardiovas-
cular disease: evidence on causality from a meta-analysis.
BMJ 2002;325:1202-8.
3 Homocysteine Studies Collaboration. Homocysteine and
risk of ischaemic heart disease and stroke: a meta-analysis.
JAMA 2002;288:2015-22.
4 Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten
EG, et al. MTHFR 677CT polymorphism and risk of
coronary heart disease: a meta-analysis. JAMA
2002;288:2023-31.
5 Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D,
et al. Randomised trial of folic acid supplementation and
serum homocysteine levels. Arch Intern Med 2001;161:
695-700.
Authors’ reply
Editor—Wald et al oversimplify the relation
between serum folate concentration and cor-
onary heart disease, and they have ignored
our results for red cell folate, a more reliable
indicator of long term folate intake than
serum folate. The reference interval for red
cell folate in our cohort was 114-608 g/l in
men and 101-604 g/l in women, indicating
a wide range of folate values consonant to
that reported in other general populations.
The power of our study to detect a relative
risk of 1.2 associated with a change of one
standard deviation (130 g/l for red cell
folate) was about 90% for death from cardio-
vascular disease and 70% for death from cor-
onary heart disease.
Wald et al state that serum folate needs to
increase by 20 g/l to lower the risk of coron-
ary heart disease by 16% on the premise of
lowering homocysteine concentrations by 3
mol/l.1 However, the Framingham heart
study showed a difference > 5 mol/l in
mean homocysteine concentrations across
the population within a comparatively nar-
row range of serum folate values from 2 to 8
g/l.2 We found similar results in a general
population.3
Furthermore, the effect of raising folate
concentration can be underestimated by the
reduction in mean homocysteine concentra-
tion. For example, a population increase in
serum folate from 4.6 to 10.0 g/l decreased
the prevalence of high homocysteine ( > 13
mol/l) from 18.7% to 9.8% but reduced
mean homocysteine concentration by only
0.7 mol/l.4
Folates should not be assumed to
prevent coronary heart disease only
through lowering homocysteine concentra-
tion as other mechanisms may exist.5 Hence
we did not argue against public health
efforts to raise folate consumption in the
general population by appropriate dietary
measures. We argued against the routine use
of vitamin supplements to lower homo-
cysteine concentrations in the general
population until their benefit is proved by
controlled clinical trials.
Joseph Hung associate professor
jhung@dph.uwa.edu.au
John P Beilby senior biochemist
Matthew W Knuiman associate professor
Mark Divitini research associate
School of Medicine and Pharmacology, University
of Western Australia, Nedlands, WA 6009, Australia
Competing interests: None declared.
1 Wald DS, Law M, Morris JK. Homocysteine and cardiovas-
cular disease: evidence on causality from a meta-analysis.
BMJ 2002;325:1202-8.
2 Tucker KL, Mahnken B, Wilson PWF, Jacques P, Selhub J.
Folic acid fortification of the food supply. Potential benefits
and risks for the elderly population. JAMA 1996;276:1879-
85.
3 McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung
J. Hyperhomocysteinemia but not the C677T mutation of
methylenetetrahydrofolate reductase is an independent
risk determinant of carotid wall thickening. The Perth
carotid ultrasound disease assessment study (CUDAS).
Circulation 1999;99:2383-8.
4 Jacques P, Selhub J, Bostom AG, Wilson PWF, Rosenberg
IH. The effect of folic acid fortification on plasma folate
and total homocysteine concentrations. N Engl J Med
1999;340:1449-54.
5 Verhaar MC, Stroes E, Rabelink TJ. Folates and cardiovas-
cular disease. Arterioscler Thromb Vasc Biol 2002;22:6-13.
Chronic cough
Article is not consistent with WHO
initiative on rhinitis and asthma
Editor—The discussion on rhinitis in the
article on chronic cough in the 10-minute
consultation series seems inconsistent with
the World Health Organization’s recent ini-
tiative on allergic rhinitis and its impact on
asthma.1 2
The classification of rhinitis used (“per-
ennial” and “seasonal”) has been superseded
by the subdivisions “intermittent” and
“persistent” rhinitis, graded “mild,” “moder-
ate,” or “severe,” which is believed to have
advantages in understanding the condition
and in guiding treatment. The initiative lists
pharmacological options as oral or local
decongestants, oral or local antihistamines,
intranasal corticosteroids, and local anti-
cholinergics, with other options including
systemic corticosteroids, local chromones
and antileucotrienes.
In mild intermittent rhinitis, antihista-
mines are recommended as first line
treatment, with the addition of nasal cortico-
steroids or chromones for moderate to
severe intermittent disease. Nasal steroids
are recommended for earlier use in persist-
ent disease, with the addition of ipratropium
if rhinorrhoea is prominent. This algorithm
is different from that presented in the article.
The article is also not clear on what is
meant by “non-allergic rhinitis” or how gen-
eral practitioners are to differentiate it from
allergic rhinitis other than by skin prick or
radioallergosorbent testing to aeroallergens.
These investigations are commonly available
in primary care, but current evidence is lack-
ing on the clinical or cost effectiveness of
routine testing. No reference is made to jus-
tify the debatable first line use of ipratro-
pium in non-allergic rhinitis.
Although the article makes useful points
on the differential diagnosis and the
management of patients with chronic
cough, consistent messages need to be given
on important and common conditions such
as rhinitis.
Mike Thomas General Practice Airways Group
clinical research fellow
mikethomas@doctors.org.uk
David Price General Practice Airways Group professor
of primary care respiratory medicine
Department of General Practice and Primary Care,
University of Aberdeen, Foresterhill Health Centre,
Aberdeen AB25 2AY
Competing interests: None declared.
1 Currie G, Gray R, McKay J 10 minute consultation:
Chronic cough. BMJ 2003;326:261. (1 February.)
2 Bousquet J, Van-Cauwenberge P, Khaltaev N and the
ARIA group. Allergic rhinitis and its impact on asthma. J
Allergy Clim Immunol 2001; 108 (suppl):S147-S333.
Don’t forget pertussis. . .
Editor—The 10-minute consultation on
chronic cough did not mention pertussis
(whooping cough), a common yet under-
recognised infection in adults.1 We have
become increasingly aware of the clinical
significance of pertussis in our general prac-
tice population, confirming infection in
numerous patients, including previously
vaccinated children, middle aged adults, and
elderly patients.2 The recent addition of per-
tussis vaccine to the United Kingdom
preschool booster acknowledged the
endemic nature of this problem.
Typically, patients have a tracheal cough
that is worse at night and on exercise. Vomit-
ing with coughing is frequent, and an
audible whoop may develop. Symptoms
tend to last for three months, and the
characteristic cough may return with subse-
quent viral respiratory infections. Confirma-
tion of pertussis infection is by culture from
nasal swabs in cases presenting early or by
serological investigation.
When the diagnosis is suspected,
patients should be investigated appropri-
ately. The respiratory and systemic infection
Letters
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laboratory of the Central Public Health
Laboratory will undertake serological inves-
tigation of patients with a persistent cough
(exceeding three weeks). The chief advan-
tage in making the diagnosis is in avoiding
confusion with other conditions, such as
asthma. This is a concern because a
therapeutic trial of asthma drugs may
coincide with natural resolution of pertussis
infection. Recognition of pertussis can also
help to ensure infected persons minimise
their contact with young prevaccinated
babies.
Andrew M Ross general practitioner
Northfield Medical Centre, Birmingham B31 1QT
andrew.ross@pc.birminghamha.wmids.nhs.uk
Douglas M Fleming director
Royal College of General Practitioners Research
Unit, Birmingham B17 9DB
Competing interests: None declared
1 Currie G, Gray R, McKay J 10 minute consultation:
Chronic cough. BMJ 2003;326:261. (1 February.)
2 Miller E, Fleming DM, Ashworth LAE, Mabbett DA,
Vurdien JE, Elliot TSJ. Serological evidence of pertussis in
patients presenting with cough in general practice in
Birmingham. Commun Dis Public Health 2000,3:132-4.
. . .tuberculosis . . .
Editor—Currie et al summarise the issues
and differential diagnosis of patients pre-
senting in primary care with a chronic
cough.1 They suggest arranging chest radio-
graphy in smokers and in people at risk of
tuberculosis or immunosuppression, as well
as in non-smokers if the diagnosis is not
clear.
An outbreak of tuberculosis at a school
in London in 2001 highlights how doctors
must be ever vigilant of tuberculosis, and not
just in people at risk of acquiring the disease.
This outbreak led to a total of 251 adults and
children needing screening. A total of 12
more cases of tuberculosis disease and 55
cases of infection were discovered; six of the
cases of tuberculosis disease were children.
The outbreak investigation found that
neither the index case nor any of those who
were found to have disease and infection fell
into any of the risk categories. The index
case was seen by a series of primary care
doctors, then in secondary care, as an NHS
patient and in the private sector, and yet
tuberculosis was not considered. Even chest
radiology for atypical shoulder pain
reported the lungs to be clear; this was later
discovered not to be the case. Tuberculosis
was diagnosed 18 months after the initial
contact and only when the index case had
been admitted to an accident and emer-
gency department after collapsing while
away from home.
Consultation skills, thorough history
taking, and continuity of care are necessary.
Rapid access to any primary care profes-
sional in the practice may reduce the
common thread of thought that helps to
identify the unusual presentation of a
common problem.
Peter B Graves health strategy consultant
peter.graves@swlha.nhs.uk
Yvonne Doyle director of public health
South West London Strategic Health Authority,
London SW19 3RG
Competing interests: None declared.
1 Currie G, Gray R, McKay J. 10 minute consultation:
Chronic cough. BMJ 2003;326:261. (1 February.)
. . .and tropical pulmonary eosinophilia
Editor—Tropical pulmonary eosinophilia
is one of the commonest causes of chronic
cough in tropical regions where filariasis is
endemic. It may occur after infection with all
types of nematodes causing filariasis. The
disease results from a hypersensitivity
reaction to the microfilariae in the capillar-
ies of the alveoli.1 It is common among non-
immune visitors to endemic areas.
The disease is characterised by paroxys-
mal cough occurring especially during the
night, wheezing, malaise, sometimes low
grade fever, and hypereosinophilia. The
absence of microfilariae from the blood and
raised concentrations of serum total immu-
noglobulin E > 1000 IU/ml support the
diagnosis.
Early diagnosis and treatment is neces-
sary as untreated disease may result in long
term sequelae such as pulmonary fibrosis or
chronic bronchitis with respiratory failure.2
The condition used to be seen only in
people living in the tropics, but increased
travelling has made it more common in the
West. Since the clinical symptoms overlap
with those of many other conditions that
cause chronic cough—such as asthma,
sinusitis, etc—doctors need to be aware of
the possibility of tropical pulmonary eosi-
nophilia in a patient who presents with a
chronic cough.
G N Malavige lecturer in microbiology
Department of Microbiology, Faculty of Medical
Sciences, University of Sri Jayawardenapure, Sri
Lanka
neelika@lassana.com
Competing interests: None declared.
1 Ong RK, Doyle RL. Tropical pulmonary eosinophilia.
Chest 1998;113:1673-9.
2 Currie G, Gray R, McKay J 10 minute consultation:
Chronic cough. BMJ 2003;326:261. (1 February.)
Leishmaniasis also occurs in
Mediterranean countries
Editor—The clinical review on leishmania-
sis by Davies et al focuses on new
developments in developing countries,
where the disease is endemic.1 However,
leishmaniasis also occurs in all Mediterra-
nean areas, although the incidence of the
disease fell sharply after the intensive spray-
ing with antimalarial insecticide (DDT,
dicophane) during the 1950s to reclaim land
and improve housing conditions. Before
1948 our department used to see an average
of 143 cases of visceral leishmaniasis yearly
(range 20-302); subsequently the number
fell to 10 (range 2-22).
People at risk are not only those living in
Mediterranean countries but also holiday-
makers. The incubation time may be as long
as two years, so the typical symptoms (fever,
anaemia, spleen enlargement) may arise
long after the return home, and it may be
difficult to reach the correct diagnosis.
All doctors should strongly suspect
leishmaniasis when its typical symptoms
arise in someone who has spent some time
where the disease is endemic, including
Mediterranean countries. However, even
Sicilian family doctors rarely think of
leishmaniasis and often refer patients to our
department with a clinical suspicion of
malignancy.
Giovanna Russo associate professor
Department of Pediatrics, University of Catania, Via
Santa Sofia 78, I-95123 Catania, Italy
diberuss@unict.it
Competing interests: None declared.
1 Davies CR, Kaye P, Croft SL, Sundar S. Leishmaniasis: new
approaches to disease control. BMJ 2003;326:377-82, (15
February.)
Medical experts and the
criminal courts
Meaningful audit could be difficult to
attain
Editor—Although I agree with Milroy, I
think it unfortunate that he did not extend
his editorial to propose a system for the
auditing and assessment of quality in
medicolegal work.1 Experience shows that
meaningful audit could be very difficult to
attain for many reasons that include the fol-
lowing five.
The first is the legal system. The
adversarial system is simply one of winning
and not one of finding the truth. This
encourages the use of “hired guns” and
brings pressure on experts from both sides
to provide “favourable” reports in the inter-
ests of maintaining client satisfaction and
obtaining further medicolegal work.
The second is the absence of evidence
based forensic medicine. Properly con-
ducted research in the field has been
comparatively limited and many of the
forensic “facts” are neither supported by nor
based on controlled research findings but
on published personal views.
The third is personalities and titles.
Personality conflicts and favouritisms can
interfere in the objective assessment of per-
formance and the establishment of a list of
accredited “experts.” Titles are a problem as
professorial and associate professorial
appointments are not always indicators of
either knowledge or competence, although
are often viewed as such, particularly in the
courts.
The fourth is representation. People
who provide medicolegal services are
associated with a wide variety of learned
societies and colleges. Most do not have
effective audit systems in place, and even if
they did, no uniform standard exists across
all fields.
The last is assessment of court perform-
ance. Court presentation is an important
aspect for any medicolegal practitioner but
can this be objectively and inexpensively
assessed?
Audit and quality assurance pro-
grammes are certainly necessary and are
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long overdue but the implementation of an
objective system free from bias could be very
difficult. Many changes are needed includ-
ing consideration of both national and
international governing bodies that are
inclusive of all medicolegal practitioners.
John A M Gall forensic physician
Australian Forensic and Medico-Legal
Practitioners, PO Box 2491, Kew 3101, Australia
johngall@bigpond.com
Competing interests: None declared.
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Clinical forensic medicine needs to
become part of the syllabus
Editor—Although Milroy was discussing
expert medical witnesses,1 he might have
usefully broadened his review to include
professional medical witnesses. In our
increasingly violent society doctors often
give factual evidence about injuries;
although professional witnesses, they also
give expert opinions on their causation.Mis-
carriages of justice may and do occur when
their knowledge base is inadequate.
Criminal medicolegal problems are not
restricted to forensic pathology, a recog-
nised specialty. Clinical forensic medicine,
needed to ensure competence when evaluat-
ing injuries due to criminal trauma, is not
even a subspecialty. Considering the num-
bers of patients presenting in accident and
emergency departments with such injuries,
the necessity for training in this discipline is
self evident. Ninety per cent of victims of
domestic violence are seen in general
practice, where the same caveat applies.
Although the General Medical Council
pays lip service to the legal aspects of medi-
cine, clinical forensic medicine is conspicu-
ous by its absence in the undergraduate
syllabus. Neither do the royal medical
colleges show any interest in taking steps to
improve medical evidence in criminal cases.
The new Council for the Registration of
Forensic Practitioners will work towards
accreditation of forensic medical examiners
for the various constabularies, but this will
do nothing for most general practitioners or
doctors in accident and emergency medi-
cine who may find themselves stranded in
the witness boxes of magistrate and crown
courts.
For decades doctors at the criminal
medicolegal interface have unsuccessfully
sought sponsorship from academic bodies
to build an organisation dedicated to
remedying this deficiency. The legal profes-
sion should help its medical sister put her
house in order and bring pressure to bear
where it will help most. It would be interest-
ing to hear Lord Justice Auld’s views on this
proposition.
Neville Davies consultant occupational and forensic
physician
Redroofs, Windmill Lane, Arkley, Hertfordshire
EN5 3HX
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Involving community may be
way forward post-Shipman
Editor—Baker et al monitored mortality in
general practice after Shipman.1 A statistical
monitoring process with high enough sensi-
tivity to detect murder would almost certainly
give many false positive signals. This could
cause severe damage both to practitioners
and to their relationships with their patients.
A statistical monitoring process with
high enough specificity to avoid false
positive signals may take so long to signal
that many preventable deaths could occur. A
practitioner bent on deliberate murder
would almost certainly be expert at gaming
any such monitoring process. Requiring
groups of practitioners to review the deaths
in their practices at regular intervals with a
view to improving the quality of patient care
is an excellent idea, but it is difficult to see
how this would deter a murderer.
It is essential for dealing with substand-
ard performance that the underlying system
is first analysed carefully and fixed. Judg-
mental monitoring without that first essen-
tial step is likely to generate an environment
in which “proving that you comply with the
benchmark,” if necessary by employing
gaming, becomes the norm at the expense
of using data to learn how to do better. Such
an environment guarantees poor morale
and mediocre performance.
When confronted with problems such as
that of Shipman, the bureaucratic response is
often centralised, unwieldy, damaging to trust,
and costly.Often a solution that is more effec-
tive, capable of enhancing trust, and much
less costly can be found—for example, by
involving the community in the process.
Communities that support a general prac-
titioner will usually have a lawyer, accountant,
or justice of the peace. With suitable training
such people could be involved in the death
certification process. There may be better
ways of involving the community, but this idea
illustrates the principle involved.
Anthony P Morton visiting staff
Princess Alexandra Hospital, Brisbane, Queensland
4102, Australia
apmorton@bigpond.com.au
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Cleft lip and palate services
still need to be improved
Editor—The report of the Clinical Stand-
ards Advisory Group in 1998 was highly
critical of the care for people with cleft lips
and palates in the United Kingdom.1 2
Fundamental recommendations included
reducing the 57 cleft units to between eight
and 12. This represented roughly one cleft
centre for each of the areas covered by the
old regional health authorities. The report
was accepted in full by the Department of
Health and endorsed by every major profes-
sional association concerned with cleft care.
Cleft lip and palate services were identi-
fied as a national priority,3 and a commission-
ing framework was produced to ensure that
the recommendations were implemented.
NHS trusts and health authorities were in-
structed to review their services to ensure that
these were consistent with this framework.4
The service, directed by an implementa-
tion group,5 was to be in place no later than
1 April 2000. Regrettably, this has not
happened, and although some centres have
now been established, several regions have
not even reached the stage of public consul-
tation. In some areas trusts, managers, and
clinicians are at loggerheads, with no resolu-
tion of the problems in sight.
It is astonishing that five years after the
clinical standards advisory group’s report
was published we are still some distance from
implementing its recommendations. The
delay to service has resulted in considerable
frustration and anxiety to clinicians and
patients alike. Furthermore, recruitment to
the service may be difficult to achieve as able
clinicians may decide not to enter a specialty
with such an uncertain future.
The Department of Health must take
control and fulfil the promises made when
the report was accepted.
D Roberts-Harry president, Craniofacial Society of
Great Britain and Ireland
Cleft Lip and Palate Service, General Infirmary,
Leeds LS2 9NS
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Encouraging insensitivity in
doctors is not an option
Editor—There may be a sense in which
being a caring doctor may be bad for you, as
suggested by Sweet in her report of a study
into the psychological health of students
from University of Sydney medical pro-
gramme.1 With the changes in medical edu-
cation over recent years, many medical
schools now have similar aims to this
programme, which are to produce medical
graduates who are committed to rational,
compassionate health care and medical
research of the highest quality.2
However, it is not helpful to encourage
insensitivity in doctors as an option.3 It is
important to differentiate between being
uncaring and being defensive about caring
too much.4 Doctors do have to cope with
emotionally difficult situations.
Doctors feel exposed in modern health
systems.5 They may no longer have their
traditional defences to fall back on. The
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private, individual contractual relationship
with patients may need regulating, and state
and social insurance systems create responsi-
bilities for employers. Personal vulnerability
may be difficult to negotiate openly and hon-
estly with patients. Tolerating uncertainty may
be anxiety provoking. More research is
required to investigate such personal and
professional pressures and their impact.
D B Double consultant psychiatrist
Norfolk Mental Health Care NHS Trust, Norwich
NR6 5BE
dbdouble@dbdouble.co.uk
Competing interests: None declared.
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Senior medical staff need to be
included in severe asthma
Editor—Rees has drawn attention to the
importance and usefulness of the new
asthma guidelines, but he questioned the
necessity of adding the authors’ view that
senior medical staff should be consulted in a
situation where there is clear evidence of
benefit (use of intravenous magnesium for
severe asthma).1
As a member of the group developing
guidelines for the management of acute
asthma for the British Thoracic Society-
Scottish Intercollegiate Network, I would
like to clarify the reason for including this
advice in the guidelines. A weakness of the
previous guidelines from the British Tho-
racic Society was the absence of clear advice
concerning the involvement of senior staff
in the care of patients at high risk. It was
common for junior staff to manage severely
ill patients and to administer treatments
such as aminophylline, which could cause
serious side effects without discussing the
patient with senior staff.
Intravenous magnesium has been
shown to be beneficial and safe in the man-
agement of severe asthma. The guidelines
recommend that it should be given to
patients with life threatening asthma, near
fatal asthma, or patients with acute severe
asthma whose condition has not responded
well to initial treatment. The guideline
development group thought that it was
important to involve senior medical staff (or
intensive care staff) in the care of this small
group of high risk patients. The use of intra-
venous magnesium was seen as a useful trig-
ger to identify these high risk patients or
non-responding patients, who clearly
require discussion with senior medical staff.
B Ronan O’Driscoll consultant respiratory physician
Hope Hospital, Salford, M6 8HD
ronan.o’driscoll@srht.nhs.uk
Competing interests: BRO’D is a member of the
BTS-SIGN Guideline Development Group for
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Difficulties in giving fully
informed consent
Editor—Willison et el report that most
patients would prefer the opportunity to pro-
vide consent before anonymised information
from their electronic medical records was
used for research.1 They point out there are
major logistical challenges to obtaining such
informed consent, especially in primary care,
where ethical concerns prohibit researchers
from contacting patients directly.2
Gaining informed consent from each
individual in a research study including thou-
sands of patients may fall to general
practitioners and practice staff, who already
have a heavy workload. The additional
resource and financial costs would be consid-
erable. General practitioners are unlikely to
agree to do this. Thus primary care research
using anonymised electronic data may grind
to a halt and one of the advantages of
electronic patient records may be lost.
Another difficulty is giving people all the
relevant information about a complex issue.
The participants in the study seem not to
have been given information about the costs
of obtaining their consent or the possible
consequence of the research being discon-
tinued. Would their responses have been the
same if they had been aware of the wider
implications? Many patients may not want
time and resources to be spent in this way
and may also agree with the duty of social
responsibility.3 Individual informed consent
might sometimes be inappropriate.3
In New Zealand patients are assumed to
have given consent if they are registered
with practices affiliated with the computer
research network of the Royal New Zealand
College of General Practitioners.4 These
practices put notices in their offices, stating
that information from a patient’s consulta-
tion, investigation, or referral may be used
for research once it is stripped of identifying
data.
Other solutions are needed that respect
patient autonomy without stifling primary
care research. Finding ways of improving
public knowledge about the research process
when using anonymised data is also required.
Ruth G Jepson research fellow
ruth.jepson@ed.ac.uk
Roma Robertson research assistant
Department of General Practice, University of
Edinburgh, Edinburgh EH8 9DX
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Parents are not homogeneous
Editor—Young et al offer an important
insight into the rub between parental desires
to protect their offspring from unpleasant
news while at the same time recognising
their child’s autonomy.1 However, the paper
falls short in two respects.
Firstly, although Young et al say that they
did not address the influence of sex, this fac-
tor cannot be simply discounted without
explanation. Upholding the argument that
qualitative data need analysis by sex is the
recognition of the existence of women’s
health movements and policies and of litera-
ture pertaining to men’s health on the basis
of salient social theories. Young et al needed
to recognise that the discourse of male chil-
dren and young adults did not or did, in
some way, differ from those of their female
counterparts.
Secondly, the voices of the mothers and
fathers were aggregated into a single factor,
that of “the parent.” Although not uncom-
mon in family research, this approach to
analysing the data assumes that male and
female parents or guardians have the same
relationship with their children.
This is contrary to literature exploring
relations between the sexes in families. One
parent may have a closer understanding of
the information needs of their child in times
of serious illness. Adding to the call for a dis-
aggregation of data relating to parental dis-
course is an understanding that mothers
tend to be the nexus between their family
and health professionals. Therefore women
are more likely to be the brokers of health
information and the key decision makers as
to what information is selectively leaked to
family members. Men are more likely to
concur with their spouse’s or partner’s
opinion because they are perceived to be
better informed on health and family
matters. A verbatim account of interparent
discussions as to why health information
should be withheld would be a valuable
prelude to Young et al’s work as it stands.
Tom A Laws lecturer
University of South Australia, Adelaide, SA 5000,
Australia
tom.laws@unisa.edu.au
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